Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Udamin SP
- Development stage
- Unknown
- Lead developer
- Poly Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Udamin SP is a prescription-strength multivitamin and mineral supplement specifically formulated to support prostate health in older patients. Developed by Poly Pharmaceuticals, it contains a combination of essential vitamins (A, C, D, E, and B-complex, including cyanocobalamin) and minerals (calcium, iron, zinc, and magnesium). It is marketed as a dietary supplement for urological health, particularly for individuals showing signs or symptoms of prostate issues or those at higher risk. The product is typically administered as a twice-daily formula to provide nutritional support for prostate cellular health and metabolic function.
- Brand names
- Udamin SP
Beyond the preview
Go deeper on Udamin SP.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Udamin SP.